Hawk70 you haven’t answered me why is AGN at a 100 million...

First 54 Last

Share
Profile

Follow
Roch2077

10,004 Posts.

1965

10/05/24

12:20

Post #: 73762116
Share

Originally posted by Hawk70: ↑

then explain to me when they check for side effects and that the drug is targeting and functioning correctly in phase 1 study is not human trials?

They don't check if the drug is 'targeting or functioning' in a stage 1 trial.

It's given to ensure it doesn't kill anyone or give longer term effects that will prevent it being used in the future.

It's not testing if it 'renews' the brain after a CVA - what, you think Nyrada has a whole team wandering Melbourne waiting for someone to have a stroke and give a completely untested drug within 45 minutes of injury?

Seriously?

This trial - and it hasn't even been registered with the medical ethics board (yes, you have to register) is purely to see if it is harmful to healthy humans.

That's all.

And healthy at administration, 1 week, 1 month 3 months 6 months and 12 months.

Takes a damn year to get clearance.

Show me anywhere outside of promotional company bump that this trial is going ahead this year. Just the ad requesting paid volunteers will do.

Anything.

A human trial testing the drug to see if it works post CVA takes years to set up and costs tens of millions of $$$

I hope to goodness people don't believe the things you post because they are completely wrong.

PS: Who said they were going broke? I said the SP will drift back down to 2c - and it will, as the only thing of note is a 16 mice trial.

The share price has nothing to do with how much $$ you have in the bank.

If you are sitting on profit, take it and run. You've already seen it drop from 11c to 7c.

Expand

Hawk70 you haven’t answered me why is AGN at a 100 million market cap on pre clinical results? And apparently they need to wait 10 years phase 2 but started it within 3 months after phase 1 so what’s going on? Please explain in detail ?

Also NYR are 12 months behind AGN in development of the drug but NYR has the US Army on top of that

NYR - 10 million in funding and 10 million market cap
AGN - 100 million market cap and 20 million in funding

GLP results coming up which are already de risked and then we move into phase 1 and Walter reed which is derisked from 2012 pre clinical study then FDA submission in Feb and then phase 2 with funding from the US defence force.

100 million market cap is coming in and filling my final accumulation. 10 million market cap and 10 million in funding funny

Last edited by Roch2077: 10/05/24

NYR Price at posting: 7.2¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply